Search Results 1091-1100 of 16493 for herd immunity

  1. Medical Research & Education - Mayo Clinic News Network

    Science Saturday: Scientists link enzyme to immune suppression in cancer featured image. Cancer. Science Saturday: Scientists link enzyme to immune ...

  2. Adult health Eye care - Mayo Clinic

    Heart attack prevention: Should I avoid secondhand smoke? Herd immunity and coronavirus · Hidradenitis suppurativa and sleep: How to get more zzz's · Home ...

  3. A Study to Learn More About Experiences of Patients with Genetic Risk for Breast Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Ewing sarcoma - Doctors and departments - Mayo Clinic

    Learn about diagnosis and treatment of this bone and soft tissue cancer, including chemotherapy, radiation, proton beam therapy and limb-saving surgery.

  5. Medical Research & Education - Mayo Clinic News Network

    Immune response to ovarian cancer may predict survival, Mayo-led study finds featured image. Cancer. Immune response to ovarian cancer may predict survival ...

  6. Gastroenterology and Hepatology - Clinical trials

    Rochester, Minn. This is a survey study to describe how women with Lynch syndrome are being screened for gynecologic cancer risk, their perception of cancer ...

  7. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers demonstrate nearly 20% boost in adolescent HPV vaccination rates using comprehensive strategy · Study shows immune molecule may play key ...

  8. A Study of AO-176 as Monotherapy Combinated with Bortezomib and Dexamethasone in Adults with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Resolution of prior therapy-related AEs (including immune-related AEs but excluding alopecia) to ≤ Grade 1 (except for Grade 2 peripheral neuropathy) per CTCAE ...

  9. Chronic Intestinal Pseudo Obstruction de novo Clinical Outcomes Assessment

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. A Study to Evaluate if Benralizumab Compared to Mepolizumab May be Beneficial in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) - Mayo Clinic

    The OLE period is intended to allow each patient at least 1 year of treatment with open-label benralizumab 30 mg administered SC every 4th week (earlier ...